Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate the Effectiveness and Safety of RXI 109 on the Outcome of Scar Revision Surgery in Healthy Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02030275
Recruitment Status : Completed
First Posted : January 8, 2014
Last Update Posted : June 21, 2016
Sponsor:
Information provided by (Responsible Party):
RXi Pharmaceuticals, Corp.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 2016
Actual Study Completion Date : June 2016